Abstract

Magnetic resonance imaging (MRI) and positron emission tomography (PET) are neuroimaging modalities typically used for evaluating brain changes in Alzheimer’s disease (AD). Due to their complementary nature, their combination can provide more accurate AD diagnosis or prognosis. In this work, we apply a multi-modal imaging machine-learning framework to enhance AD classification and prediction of diagnosis of subject-matched gray matter MRI and Pittsburgh compound B (PiB)-PET data related to 58 AD, 108 mild cognitive impairment (MCI) and 120 healthy elderly (HE) subjects from the Australian imaging, biomarkers and lifestyle (AIBL) dataset. Specifically, we combined a Dartel algorithm to enhance anatomical registration with multi-kernel learning (MKL) technique, yielding an average of >95% accuracy for three binary classification problems: AD-vs.-HE, MCI-vs.-HE and AD-vs.-MCI, a considerable improvement from individual modality approach. Consistent with t-contrasts, the MKL weight maps revealed known brain regions associated with AD, i.e., (para)hippocampus, posterior cingulate cortex and bilateral temporal gyrus. Importantly, MKL regression analysis provided excellent predictions of diagnosis of individuals by r2 = 0.86. In addition, we found significant correlations between the MKL classification and delayed memory recall scores with r2 = 0.62 (p < 0.01). Interestingly, outliers in the regression model for diagnosis were mainly converter samples with a higher likelihood of converting to the inclined diagnostic category. Overall, our work demonstrates the successful application of MKL with Dartel on combined neuromarkers from different neuroimaging modalities in the AIBL data. This lends further support in favor of machine learning approach in improving the diagnosis and risk prediction of AD.

Highlights

  • Magnetic resonance imaging (MRI) and positron emission tomography (PET) are two imaging data modalities that are routinely used for evaluating changes in the brain associated with Alzheimer’s disease (AD) (Ewers et al, 2011; Bateman et al, 2012)

  • Based on the ANOVA test, we identified eight features which were significantly linked to AD progression

  • We have applied a machine-learning framework based on multimodal analysis for AD classification and prediction of the AIBL data

Read more

Summary

Introduction

Magnetic resonance imaging (MRI) and positron emission tomography (PET) are two imaging data modalities that are routinely used for evaluating changes in the brain associated with Alzheimer’s disease (AD) (Ewers et al, 2011; Bateman et al, 2012). Biomarkers from these neuroimaging data are crucial for identifying early symptoms of AD pathology. In most cases, one biomarker is not sufficient for an accurate diagnosis or prognosis of the disease because each modality reveals information about different aspects of the underlying pathology (Hinrichs et al, 2011)

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.